AstraZeneca, Merck announce promising results for breast cancer in trial 3
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World
HQ Team December 11, 2024: The U.S. Food and Drug Administration (FDA) has announced a halt to all clinical trials for respiratory syncytial
Vinit Shetty December 9, 2024: We bring you here the blogs of Mr Vinit Shetty, encapsulating his remarkable journey with sensorimotor neuropathy. Though
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for
Thirty-one people, mostly children, have died due to an undiagnosed disease in the Democratic Republic of Congo, the WHO stated
Bharti Jayshankar December 9, 2024: A study conducted in Malawi suggests that chewing gum containing xylitol, a natural sugar alcohol, could significantly lower